Bolt Biotherapeutics, Inc.
BOLTNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $7.17M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.10$7.20
- Volume (live)
- -
- Avg. volume (3M)
- 33.98K
Bolt Biotherapeutics (BOLT) Stock Price & Financial Analysis
Bolt Biotherapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.96 - $4.48 |
|---|---|
| 52-Week High | $7.20 |
| 52-Week Low | $3.10 |
| Open | $4.46 |
| Volume (last close) | 10.12K |
| Average Volume (3M) | 33.98K |
| Revenue (TTM) | 4.70M |
|---|---|
| Net Income (TTM) | -28.74M |
| Free Cash Flow (TTM) | -31.54M |
| EPS (TTM) | −$15.95 |
| Profit Margin | -611.47% |
| Operating Margin | -605.85% |
| Return on Equity (ROE) | -227.37% |
| Debt to Equity | 1.71 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 7.17M |
|---|---|
| Shares Outstanding | 1.69M |
| Price to Sales (P/S) | 1.53 |
| Price to Book (P/B) | 0.57 |
| EV/EBITDA | -0.60 |
| 50-Day MA | $3.72 |
|---|---|
| 200-Day MA | $4.54 |
| 1-Year Change | −26.27% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Bolt Biotherapeutics at a Glance
As of the Oct 16, 2026 close, Bolt Biotherapeutics (BOLT) has a market capitalization of $7.17M. The stock trades at 1.5× sales. Over the trailing twelve months it lost $28.74M on revenue of $4.70M and burned $31.54M of free cash flow. Revenue grew 12.8% year over year.
As of its latest reported balance sheet, it holds $12.86M in cash and securities against $21.62M of debt, a net debt position of $8.76M.
Bolt Biotherapeutics does not currently pay a dividend.
The share price is down 26.3% over the past year. At $4.00 (the Oct 16, 2026 close) it sits within its 52-week range of $3.10 to $7.20, below its 200-day moving average of $4.54.
Based on 1 professional analyst rating from the past 90 days, the consensus is Hold.
Frequently Asked Questions About Bolt Biotherapeutics
What is the current stock price for BOLT?
As of the Oct 16, 2026 close, BOLT stock trades at $4.00. The 52-week range is $3.10–$7.20, with a day range of $3.96–$4.48.
What is the P/E ratio for BOLT?
The P/E ratio (Price-to-Earnings) for BOLT is shown in the Key Statistics section. This valuation metric helps compare Bolt Biotherapeutics, Inc. to industry peers.
Does BOLT pay dividends?
Bolt Biotherapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for BOLT?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for BOLT is Hold.
What is the market cap of BOLT?
As of the Oct 16, 2026 close, Bolt Biotherapeutics's market capitalization is $6.8M, classifying it as a micro-cap company. Bolt Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.